LUNG Q1 2022 Earnings — Pulmonx Corporation Revenue & Financial Results | Market Cap Arena

LUNGPulmonx Corporation

$75M

Q1 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$11M+16.7% YoY

Gross Profit

$8M75.2% margin

Operating Income

-$16M-145.3% margin

Net Income

-$16M-146.8% margin

EPS (Diluted)

$-0.43

QoQ Revenue Growth

-21.3%

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$16M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$223M

Total Liabilities

$41M

Stockholders' Equity

$182M

Cash & Equivalents

$129M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11M	$9M	+16.7%
Gross Profit	$8M	$7M	+22.7%
Operating Income	-$16M	-$12M	-25.4%
Net Income	-$16M	-$13M	-26.5%

Geographic Segments

UNITED STATES

$6M56%

EMEA

$4M38%

Asia Pacific

$719,0007%